Characteristic clinicopathologic features of epstein‐barr virus—associated peripheral T‐cell lymphoma

Cancer

Volumn 72, Issue 3, 1993, Pages 909-916

  Cheng, Ann‐Lii ^a   Su, Ih‐Jen ^a   Chen, Yao‐Chang ^a   Uen, Wu‐Ching ^a   Wang, Chiu‐Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Epstein Barr virus; hemophagocytosis; P glycoprotein; T cell lymphoma

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMAN; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; NEOPLASM PROTEINS; NEOPLASM STAGING; P-GLYCOPROTEIN; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TUMOR VIRUS INFECTIONS;

EID: 0027199311     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930801)72:3<909::AID-CNCR2820720341>3.0.CO;2-O     Document Type: Article

References (45)

1. Virus particles in cultured lymphoblasts from Burkitt's lymphoma
2. EBV‐DNA in biopsies of Burkitt's tumor and anaplastic carcinoma of the nasopharynx
3. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki‐1‐positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization
4. Expression of Epstein‐Barr virus (EBV) latent gene products in tumor cells of Hodgkin's disease
5. T‐cell lymphomas containing Epstein‐Barr viral DNA in patients with chronic Epstein‐Barr virus infection
6. Epstein‐Barr virus–associated peripheral T‐cell lymphoma of activated CD8 phenotype
7. Aggressive peripheral T‐cell lymphomas containing Epstein‐Barr viral DNA: a clinicopathologic and molecular analysis
8. Association of Epstein‐Barr virus with thymic carcinoma
9. Epstein‐Barr virus DNA and latent gene products in Ki‐1 (CD30)‐positive anaplastic large cell lymphomas
10. Small noncleaved B cell Burkitt‐like lymphoma with chromosome t(8; 14) translocation and Epstein‐Barr nuclear associated antigen in a homosexual man with acquired immune deficiency syndrome
11. Identification of EBV‐DNA in tumor cells of AIDS‐related lymphomas by in‐situ hybridization
12. National Cancer Institute sponsored study of classifications of non‐Hodgkin's lymphomas: summary and description of a working formulation for clinical usage
13. Peripheral T‐cell lymphoma and adult T‐cell leukemia‐lymphoma
14. Use of avidin‐biotin‐peroxidase complex (ABC) and unlabelled antibody (PAP) procedures
15. The structure of the termini of the Epstein‐Barr virus as a marker of clonal cellular proliferation
16. Study on IgG and IgA antibodies against EB virus in serum and saliva of naso‐pharyngeal carcinoma patients
17. Report of the Committee on Hodgkin's Disease Staging Classification
18. Nonparametric estimation from incomplete observation
19. Expression of growth‐related genes and drug resistance genes in HTLV‐I‐positive and HTLV‐I‐negative post‐thymic T‐cell malignancies
20. Cytokine expression in T‐cell lymphomas and Hodgkin's disease: its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth
21. Elevated expression of ICAM 1 (CD54) and minimal expression of LFA3 (CD58) in Epstein‐Barr‐virus‐positive nasopharyngeal carcinoma cells
22. The Epstein‐Barr virus BNLF‐1 membrane protein LMP1 induces homotypic adhesion mediated by CD11a/CD18 in a murine B‐cell line, mimicking the action of phorbol ester
23. Epstein‐Barr virus‐encoded protein found in plasma membranes of transformed cells
24. Immortalization of human T lymphocytes after transfection of Epstein‐Barr virus DNA
25. Induction of bcl‐2 expression by Epstein‐Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
26. Epstein‐Barr virus latent membrane protein inhibits human epithelial cell differentiation
27. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis
28. Angiocentric T‐cell lymphoma of the skin: an aggressive lymphoma distinct from mycosis fungoides
29. Lymphokine‐induced phagocytosis in angio‐centric immunoproliferative lesion (AIL) and malignant lymphoma arising in AIL
30. Malignant histiocytosis: a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies
31. Peripheral T‐cell lymphoma associated with hemophagocytosis syndrome
32. Fulminant childhood hemophagocytosis syndrome mimicking histiocytic medullary reticulosis: an atypical form of Epstein‐Barr virus infection
33. Expression of P‐glycoprotein in adult T‐cell leukemia cells
34. Effect of Actinomycin D and cyclohexamide on Epstein‐Barr virus early antigen induction in lymphoblastoid cells
35. Induction of Epstein‐Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C
36. Induction of Epstein‐Barr virus early antigens by intercalating chemicals in B 95‐8 cells
37. Epstein‐Barr virus nuclear protein 2 transactivates a cis‐acting CD23 DNA element
38. Isolation and sequence of the promoter region of the human multidrug‐resistance (P‐glycoprotein) gene
39. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription
40. The direct activation of human multidrug resistance gene (MDR 1) by anti‐cancer agents
41. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
42. The immunological approach to study of possible virus‐induced human malignancies using the Epstein‐Barr virus as example
43. Application of Epstein‐Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma
44. The existence of pre‐nasopharyngeal carcinoma conditions should allow preventive intervention
45. Presence of EBV‐specific IgA in saliva of nasopharyngeal carcinoma (NPC) patients: their activity, origin and possible clinical value